Start Date
May 31, 2003
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
vandetanib
adjuvant therapy
Tom Baker Cancer Centre - Calgary, Calgary
Cross Cancer Institute at University of Alberta, Edmonton
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna
Fraser/Valley Cancer Centre at British Columbia Cancer Agency, Surrey
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver
Moncton Hospital, Moncton
Saint John Regional Hospital, Saint John
Margaret and Charles Juravinski Cancer Centre, Hamilton
Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston
Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa
St. Catharines General Hospital at Niagara Health System, St. Catharines
Northwestern Ontario Regional Cancer Care at Thunder Bay Regional Health Sciences Centre, Thunder Bay
Toronto East General Hospital, Toronto
Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre, Toronto
Mount Sinai Hospital - Toronto, Toronto
Princess Margaret Hospital, Toronto
Windsor Regional Cancer Centre at Windsor Regional Hospital, Windsor
Hopital Notre- Dame du CHUM, Montreal
McGill Cancer Centre at McGill University, Montreal
L'Hopital Laval, Ste-Foy
Saskatoon Cancer Centre at the University of Saskatchewan, Saskatoon
Genzyme, a Sanofi Company
INDUSTRY